170 related articles for article (PubMed ID: 33767345)
1. Universal newborn genetic screening for pediatric cancer predisposition syndromes: model-based insights.
Yeh JM; Stout NK; Chaudhry A; Christensen KD; Gooch M; McMahon PM; O'Brien G; Rehman N; Blout Zawatsky CL; Green RC; Lu CY; Rehm HL; Williams MS; Diller L; Wu AC
Genet Med; 2021 Jul; 23(7):1366-1371. PubMed ID: 33767345
[TBL] [Abstract][Full Text] [Related]
2. Population-Based Newborn Screening for Germline TP53 Variants: Clinical Benefits, Cost-Effectiveness, and Value of Further Research.
Kunst N; Stout NK; O'Brien G; Christensen KD; McMahon PM; Wu AC; Diller LR; Yeh JM
J Natl Cancer Inst; 2022 May; 114(5):722-731. PubMed ID: 35043946
[TBL] [Abstract][Full Text] [Related]
3. Benefits, harms, and costs of newborn genetic screening for hypertrophic cardiomyopathy: Estimates from the PreEMPT model.
Christensen KD; McMahon PM; Galbraith LN; Yeh JM; Stout NK; Lu CY; Stein S; Zhao M; Hylind RJ; Wu AC
Genet Med; 2023 Apr; 25(4):100797. PubMed ID: 36727595
[TBL] [Abstract][Full Text] [Related]
4. Clinical trio genome sequencing facilitates the interpretation of variants in cancer predisposition genes in paediatric tumour patients.
Schroeder C; Faust U; Krauße L; Liebmann A; Abele M; Demidov G; Schütz L; Kelemen O; Pohle A; Gauß S; Sturm M; Roggia C; Streiter M; Buchert R; Armenau-Ebinger S; Nann D; Beschorner R; Handgretinger R; Ebinger M; Lang P; Holzer U; Skokowa J; Ossowski S; Haack TB; Mau-Holzmann UA; Dufke A; Riess O; Brecht IB
Eur J Hum Genet; 2023 Oct; 31(10):1139-1146. PubMed ID: 37507557
[TBL] [Abstract][Full Text] [Related]
5. Cost-effectiveness of Universal and Targeted Newborn Screening for Congenital Cytomegalovirus Infection.
Gantt S; Dionne F; Kozak FK; Goshen O; Goldfarb DM; Park AH; Boppana SB; Fowler K
JAMA Pediatr; 2016 Dec; 170(12):1173-1180. PubMed ID: 27723885
[TBL] [Abstract][Full Text] [Related]
6. Cost-effectiveness of universal compared with voluntary screening for human immunodeficiency virus among pregnant women in Chicago.
Immergluck LC; Cull WL; Schwartz A; Elstein AS
Pediatrics; 2000 Apr; 105(4):E54. PubMed ID: 10742375
[TBL] [Abstract][Full Text] [Related]
7. Combinatorial batching of DNA for ultralow-cost detection of pathogenic variants.
Stoltze UK; Hagen CM; van Overeem Hansen T; Byrjalsen A; Gerdes AM; Yakimov V; Rasmussen S; Bækvad-Hansen M; Hougaard DM; Schmiegelow K; Hjalgrim H; Wadt K; Bybjerg-Grauholm J
Genome Med; 2023 Mar; 15(1):17. PubMed ID: 36918911
[TBL] [Abstract][Full Text] [Related]
8. Projected costs, risks, and benefits of expanded newborn screening for MCADD.
Prosser LA; Kong CY; Rusinak D; Waisbren SL
Pediatrics; 2010 Feb; 125(2):e286-94. PubMed ID: 20123779
[TBL] [Abstract][Full Text] [Related]
9. Lack of pathogenic germline DICER1 variants in males with testicular germ-cell tumors.
Vasta LM; McMaster ML; Harney LA; Ling A; Kim J; Harris AK; Carr AG; Damrauer SM; Rader DJ; Kember RL; Kanetsky PA; Nathanson KL; Pyle LC; Greene MH; Schultz KA; Stewart DR;
Cancer Genet; 2020 Oct; 248-249():49-56. PubMed ID: 33158809
[TBL] [Abstract][Full Text] [Related]
10. A Multigene Test Could Cost-Effectively Help Extend Life Expectancy for Women at Risk of Hereditary Breast Cancer.
Li Y; Arellano AR; Bare LA; Bender RA; Strom CM; Devlin JJ
Value Health; 2017 Apr; 20(4):547-555. PubMed ID: 28407996
[TBL] [Abstract][Full Text] [Related]
11. Newborn hearing screening: the great omission.
Mehl AL; Thomson V
Pediatrics; 1998 Jan; 101(1):E4. PubMed ID: 9417168
[TBL] [Abstract][Full Text] [Related]
12.
Schultz KAP; Williams GM; Kamihara J; Stewart DR; Harris AK; Bauer AJ; Turner J; Shah R; Schneider K; Schneider KW; Carr AG; Harney LA; Baldinger S; Frazier AL; Orbach D; Schneider DT; Malkin D; Dehner LP; Messinger YH; Hill DA
Clin Cancer Res; 2018 May; 24(10):2251-2261. PubMed ID: 29343557
[TBL] [Abstract][Full Text] [Related]
13. Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan.
Hoshino E; Moriwaki K; Morimoto K; Sakai K; Shimohata N; Konomura K; Urayama KY; Suzuki M; Shimozuma K
J Pediatr; 2023 Feb; 253():101-106.e2. PubMed ID: 36179888
[TBL] [Abstract][Full Text] [Related]
14. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
Ontario Health (Quality)
Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
[TBL] [Abstract][Full Text] [Related]
15. Estimated Cost-effectiveness of Newborn Screening for Congenital Cytomegalovirus Infection in China Using a Markov Model.
Chen K; Zhong Y; Gu Y; Sharma R; Li M; Zhou J; Wu Y; Gao Y; Qin G
JAMA Netw Open; 2020 Dec; 3(12):e2023949. PubMed ID: 33275150
[TBL] [Abstract][Full Text] [Related]
16. Economic evaluation of point of care universal newborn screening for glucose-6-Phosphate dehydrogenase deficiency in United States.
Vidavalur R; Bhutani VK
J Matern Fetal Neonatal Med; 2022 Dec; 35(25):5745-5753. PubMed ID: 33627013
[TBL] [Abstract][Full Text] [Related]
17. The Colorado newborn hearing screening project, 1992-1999: on the threshold of effective population-based universal newborn hearing screening.
Mehl AL; Thomson V
Pediatrics; 2002 Jan; 109(1):E7. PubMed ID: 11773575
[TBL] [Abstract][Full Text] [Related]
18. Performance of the McGill Interactive Pediatric OncoGenetic Guidelines for Identifying Cancer Predisposition Syndromes.
Goudie C; Witkowski L; Cullinan N; Reichman L; Schiller I; Tachdjian M; Armstrong L; Blood KA; Brossard J; Brunga L; Cacciotti C; Caswell K; Cellot S; Clark ME; Clinton C; Coltin H; Felton K; Fernandez CV; Fleming AJ; Fuentes-Bolanos N; Gibson P; Grant R; Hammad R; Harrison LW; Irwin MS; Johnston DL; Kane S; Lafay-Cousin L; Lara-Corrales I; Larouche V; Mathews N; Meyn MS; Michaeli O; Perrier R; Pike M; Punnett A; Ramaswamy V; Say J; Somers G; Tabori U; Thibodeau ML; Toupin AK; Tucker KM; van Engelen K; Vairy S; Waespe N; Warby M; Wasserman JD; Whitlock JA; Sinnett D; Jabado N; Nathan PC; Shlien A; Kamihara J; Deyell RJ; Ziegler DS; Nichols KE; Dendukuri N; Malkin D; Villani A; Foulkes WD
JAMA Oncol; 2021 Dec; 7(12):1806-1814. PubMed ID: 34617981
[TBL] [Abstract][Full Text] [Related]
19. Clinical heterogeneity and reduced penetrance in DICER1 syndrome: a report of three families.
Azzollini J; Ferrari A; Stracuzzi A; Chiaravalli S; Terenziani M; Spreafico F; Grasso M; Collini P; Pensotti V; Massimino M; Arbustini E; Manoukian S
Tumori; 2021 Dec; 107(6):NP144-NP148. PubMed ID: 34761719
[TBL] [Abstract][Full Text] [Related]
20. Projected cost-effectiveness of statewide universal newborn hearing screening.
Keren R; Helfand M; Homer C; McPhillips H; Lieu TA
Pediatrics; 2002 Nov; 110(5):855-64. PubMed ID: 12415021
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
